Equities

Xinjiang Bai Hua Cun Pharma Tech Co Ltd

600721:SHH

Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Actions
TechnologyTechnology
  • Price (CNY)5.73
  • Today's Change-0.02 / -0.35%
  • Shares traded10.27m
  • 1 Year change-22.36%
  • Beta0.4600
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments20213687
Total Receivables, Net224208175
Total Inventory125149194
Prepaid expenses141211
Other current assets, total0.030.040.77
Total current assets565506468
Property, plant & equipment, net138148164
Goodwill, net111111
Intangibles, net211212
Long term investments309305308
Note receivable - long term------
Other long term assets------
Total assets1,0621,001982
LIABILITIES
Accounts payable1019358
Accrued expenses353229
Notes payable/short-term debt546375
Current portion long-term debt/capital leases0.440.51--
Other current liabilities, total11810292
Total current liabilities308289254
Total long term debt1.131.820
Total debt556575
Deferred income tax423937
Minority interest----4.95
Other liabilities, total3.743.855.29
Total liabilities355334301
SHAREHOLDERS EQUITY
Common stock382378375
Additional paid-in capital2,2582,2352,217
Retained earnings (accumulated deficit)(1940)(1953)(1918)
Treasury stock - common------
Unrealized gain (loss)7.297.437.66
Other equity, total------
Total equity707667681
Total liabilities & shareholders' equity1,0621,001982
Total common shares outstanding382378375
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.